ZIOPHARM Oncology’s (ZIOP) CEO Heidi Hagen on Q2 2021 Results – Earnings Call Transcript

ZIOPHARM Oncology, Inc. (ZIOP) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET
Company Participants
Adam Levy – Executive Vice President-Corporate Development and Investor Relations
Heidi Hagen – Interim Chief Executive Officer
Raffaele Baffa…

Click here to view the original article.